Drugs / AC-084
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02905253 | Sep 2016 → Dec 2017 | — | Idorsia Pharmaceuticals Ltd. | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AC-084 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02905253 ↗ |
| Route | Oral | “Hard gelatin capsules for oral administration” NCT02905253 ↗ |